Review
Toward an Integrated Structural Model of the 26S Proteasome*

https://doi.org/10.1074/mcp.R000002-MCP201Get rights and content
Under a Creative Commons license
open access

The 26S proteasome is the end point of the ubiquitin-proteasome pathway and degrades ubiquitylated substrates. It is composed of the 20S core particle (CP), where degradation occurs, and the 19S regulatory particle (RP), which ensures substrate specificity of degradation. Whereas the CP is resolved to atomic resolution, the architecture of the RP is largely unknown. We provide a comprehensive analysis of the current structural knowledge on the RP, including structures of the RP subunits, physical protein-protein interactions, and cryoelectron microscopy data. These data allowed us to compute an atomic model for the CP-AAA-ATPase subcomplex. In addition to this atomic model, further subunits can be mapped approximately, which lets us hypothesize on the substrate path during its degradation.

Cited by (0)

*

This work was supported by a 3D Repertoire grant and a PROSPECTS grant within the Research Framework Programs 6 and 7 (FP6 and FP7) of the European Commission, respectively, and by the Deutsche Forschungsgemeinschaft Cluster of Excellence “Munich-Centre for Advanced Photonics.” This work was also supported, in part, by National Institutes of Health Grants R01 GM54762, U54 RR022220, PN2 EY016525, and R01 GM083960 (to A. S.).

1

The abbreviations used are:

    CP

    core particle

    RP

    regulatory particle

    EM

    electron microscopy

    Rpt

    regulatory particle triple A-ATPase

    Rpn

    regulatory particle non-ATPase

    UCH

    ubiquitin C-terminal hydrolase

    PAN

    proteasome-activating nucleotidase

    PC

    proteasome cyclosome

    NPC

    nuclear pore complex

    eIF

    eukaryotic initiation factor

    TPR

    tetratricopeptide repeat

    DUB

    deubiquitylating enzyme

    BRCC

    BRCA1/BRCA2-interacting complex

    UIM

    ubiquitin interaction motif

    Ub

    ubiquitin

    PRU

    pleckstrin-like receptor of ubiquitin.

**

Supported by the Clore Foundation Ph.D. scholars program and carried out in partial fulfillment of the requirements for the Ph.D. degree at Tel Aviv University.

‡‡

Supported by the Sandler Family Supporting Foundation, National Science Foundation Grant IIS-0705196, Ron Conway, Mike Homer, Hewlett-Packard, NetApp, IBM, and Intel.